Century Therapeutics, Inc.

IPSC

$2.11

+0.72%

2026-09-04 11:09:48 EDT+$0.02

Healthcare

Biotechnology

NASDAQ

Active Trading

Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and ...

Historical Employee Count of IPSC

Current

Change

-44.29%

Minimum

Maximum

170

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	78	10-K	Mar 12, 2026	View
Dec 31, 2024	140	10-K	Mar 19, 2025	View
Dec 31, 2023	152	10-K	Mar 14, 2024	View
Dec 31, 2022	163	10-K	Mar 16, 2023	View
Dec 31, 2021	170	10-K	Mar 17, 2022	View

Supply Chain of IPSC

Upstream / Downstream / Proxies

Upstream

FUJIFILM Cellular Dynamics (FCDI)TSE:4901Inscripta / Manus BioCatalent, Inc.NYSE:CTLT Thermo Fisher Scientific Inc.NYSE:TMO Bio-Techne CorporationNASDAQ:TECHSartorius AGETR:SRT3Lonza Group AGSWX:LONNAldevron (Danaher Corporation)NYSE:DHRPluristyx, Inc.

Downstream

Bristol Myers SquibbNYSE:BMYFriedrich-Alexander University Erlangen-Nuremberg (FAU)Versant VenturesLeaps by Bayer (Bayer AG)ETR:BAYN

Proxies

Fate Therapeutics, Inc.NASDAQ:FATEFUJIFILM Holdings CorporationTSE:4901Bayer AGETR:BAYNCRISPR Therapeutics AGNASDAQ:CRSP

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer